• TIES®
  • Corporate
  • Job postings
  • Articles
  • Patients
  • General

Significant Breakthrough for Stoma Patients

Aimed to dramatically improve the patient’s quality of life, the TIES® System, a new concept in continent ileostomy receives CE marking.

OstomyCure AS Appoints new Chief Medical Officer

2017-01-31

OstomyCure today announced the appointment of Cindy Wong, M.D. as Chief Medical Officer (CMO).

Article in IA Journal: Issue 233 Autumn 2016

2016-11-10

OstomyCure AS has been published in The Ileostomy & Internal Pouch Support Groups latest issue of the IA Journal.

Experienced Chief Commercial Officer Joins OstomyCure AS

2016-09-26

OstomyCure AS engages Morten Gunvad, currently founder and Head of GP Consulting GmbH, as Chief Commercial Officer of the TIES® System.

The TIES® System represented at major political event

2016-06-29

The TIES® Implant and Lid will be represented at Almedalsveckan, an annual political event taking place in Visby, Sweden.

CE-marking for the TIES® System

2016-06-10

Today, OstomyCure is very pleased to announce that the TIES® System has received approval for CE marking from our Notified Body.

Technical File submitted for CE approval of TIES®

2016-03-24

Comprising an implantable medical device, the TIES® System requires approval from a Notified Body in order to obtain CE marking and to be marketed in Europe.

TIES® clinical study fully enrolled

2015-11-16

The ongoing TIES® clinical study is moving forward and is now fully enrolled with the planned number of patients.

OstomyCure audit upgrade to Annex II in MDD

2015-10-29

OstomyCure certification was upgraded to a higher level.

AHUS University Hospital joins the TIES® clinical study

2015-08-27

OstomyCure is pleased to announce the participation of the Ahus University Hospital in Norway in the ongoing TIES® clinical study.